During Sunday’s Super Bowl, Hims & Hers Health—a telehealth provider known for its provocative ads promoting erectile dysfunction and hair-loss treatments—aired a commercial portraying ...

During the Super Bowl, Hims & Hers Health aired a commercial called “Sick of the System.” But before the 60-second spot was played on Fox Sunday night, the ad — which deems obesity “America’s ...

A company spokesperson said the ad was a "direct response" the Hims & Hers Super Bowl commercial. The ad features a vial that reads "compounded semaglutide" and a syringe. "Some compounded ...

The ad goes on to tout Hims & Hers' weight loss ... to lawfully marketed compounded drugs for patients." Before Hims & Hers' commercial even aired, Democratic Sen. Dick Durbin of Illinois and ...

Hims & Hers made a bold move into mainstream advertising with a minute-long Super Bowl commercial. This high-stakes marketing play put the company's weight loss offerings squarely in the national ...

Pharma lobby group The Pharmaceutical Research and Manufacturers of America (PhRMA) called HIMS’ commercial “a misleading Super Bowl ad that misrepresents their unapproved GLP-1 medicines.” ...

Putting its commercial in front of all ... spokesperson told Fierce Healthcare that the ad “did a great job of driving awareness about the Hims & Hers platform.” How This Affects HIMS Stock ...

Hims & Hers saw a massive YTD surge, but FDA news led to a pullback. Find out why HIMS stock is still undervalued and why ...

A still from the 2025 Super Bowl commercial “Sick of the System,” from telehealth company Hims & Hers. © 2025 Fortune Media IP Limited. All Rights Reserved. Use ...

“The recent explosion in irresponsible and misleading advertising about compounded GLP-1 (glucagon-like peptide-1) drugs, like the Hims & Hers Super Bowl commercial, puts patients’ safety at ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.